Patent · US Active

sGC stimulators

US10639308B2 · kind B2 · utility

3Cited by
8References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 2, 2018
Grant dateMay 5, 2020
Priority date
Expiry dateNov 2, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formulae I′ and I are described, which are useful as stimulators of sGC, particularly NO-independent, heme-dependent stimulators. These compounds are also useful for treating, preventing or managing various disorders that are herein disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.